FR2340943A1 - Nouvelles 2-phenyl-5-(5-1h-tetrazolyl) pyrimidine-4(3h)-ones, leur procede de preparation et composition pharmaceutique les contenant - Google Patents

Nouvelles 2-phenyl-5-(5-1h-tetrazolyl) pyrimidine-4(3h)-ones, leur procede de preparation et composition pharmaceutique les contenant

Info

Publication number
FR2340943A1
FR2340943A1 FR7703650A FR7703650A FR2340943A1 FR 2340943 A1 FR2340943 A1 FR 2340943A1 FR 7703650 A FR7703650 A FR 7703650A FR 7703650 A FR7703650 A FR 7703650A FR 2340943 A1 FR2340943 A1 FR 2340943A1
Authority
FR
France
Prior art keywords
tetrazolyl
news
pyrimidine
ones
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7703650A
Other languages
English (en)
French (fr)
Other versions
FR2340943B1 (da
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/748,851 external-priority patent/US4082751A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2340943A1 publication Critical patent/FR2340943A1/fr
Application granted granted Critical
Publication of FR2340943B1 publication Critical patent/FR2340943B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7703650A 1976-02-13 1977-02-09 Nouvelles 2-phenyl-5-(5-1h-tetrazolyl) pyrimidine-4(3h)-ones, leur procede de preparation et composition pharmaceutique les contenant Granted FR2340943A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65778776A 1976-02-13 1976-02-13
US05/748,851 US4082751A (en) 1976-02-13 1976-12-08 Therapeutic agents

Publications (2)

Publication Number Publication Date
FR2340943A1 true FR2340943A1 (fr) 1977-09-09
FR2340943B1 FR2340943B1 (da) 1981-01-09

Family

ID=27097492

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7703650A Granted FR2340943A1 (fr) 1976-02-13 1977-02-09 Nouvelles 2-phenyl-5-(5-1h-tetrazolyl) pyrimidine-4(3h)-ones, leur procede de preparation et composition pharmaceutique les contenant

Country Status (14)

Country Link
JP (1) JPS52118481A (da)
AU (1) AU508970B2 (da)
CA (1) CA1083152A (da)
CH (1) CH635339A5 (da)
DE (1) DE2705609A1 (da)
DK (1) DK149044C (da)
FI (1) FI62533C (da)
FR (1) FR2340943A1 (da)
GB (1) GB1541351A (da)
IE (1) IE44603B1 (da)
LU (1) LU76722A1 (da)
NL (1) NL173055C (da)
SE (1) SE433494B (da)
YU (1) YU41567B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
CN101747282A (zh) * 2008-12-10 2010-06-23 上海特化医药科技有限公司 一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883653A (en) * 1972-10-24 1975-05-13 Pfizer Method of preventing asthmatic symptoms

Also Published As

Publication number Publication date
JPS52118481A (en) 1977-10-04
FI62533C (fi) 1983-01-10
NL173055C (nl) 1983-12-01
DE2705609A1 (de) 1977-08-25
FI62533B (fi) 1982-09-30
AU508970B2 (en) 1980-04-17
IE44603B1 (en) 1982-01-27
FI770427A (da) 1977-08-14
YU35477A (en) 1982-10-31
AU2189577A (en) 1978-08-10
YU41567B (en) 1987-10-31
DE2705609C2 (da) 1988-12-15
LU76722A1 (da) 1977-08-18
DK57377A (da) 1977-08-14
FR2340943B1 (da) 1981-01-09
NL7701483A (nl) 1977-08-16
DK149044B (da) 1985-12-30
CA1083152A (en) 1980-08-05
IE44603L (en) 1977-08-13
NL173055B (nl) 1983-07-01
SE7701552L (sv) 1977-09-23
JPS6139947B2 (da) 1986-09-06
SE433494B (sv) 1984-05-28
GB1541351A (en) 1979-02-28
DK149044C (da) 1986-06-02
CH635339A5 (en) 1983-03-31

Similar Documents

Publication Publication Date Title
FR2505835B1 (fr) Nouvelles 1,2-diaminocyclobutene-3,4-diones, leur procede de preparation et composition pharmaceutique les contenant
FR2518095B1 (fr) Nouveaux l-oxa-, thia- et aza-spirocyclo-benzene-acetamides et benzamides, leur procede de preparation et composition pharmaceutique les contenant
BE882113A (fr) Nouveaux 3-(1-imidazolylalkyl) indoles, leur procede de production et composition pharmaceutique les contenant
BE885269A (fr) Nouveaux tensio-actifs non ioniques, leur procede de preparation et composition les contenant
BE855405A (fr) Nouvelles 4-amino-4-arylcyclohexanones, leur procede de preparation et medicament les contenant
FR2471968B1 (fr) Ethers basiques, leur procede de preparation et compositions pharmaceutiques les contenant
FR2353530A1 (fr) Nouveaux derives de guanidine, leur procede de preparation et composition pharmaceutique les contenant
BE871769A (fr) Derives de quinazoline, leur procede de production et composition pharmaceutique les contenant
FR2351651A1 (fr) Nouvelles guanidines, leur procede de preparation et composition pharmaceutique les contenant
FR2510572B1 (fr) Nouvelles thiazolidinediones, leur procede de production et preparation pharmaceutique les contenant
BE871770A (fr) Nouveaux derives de phtalazine, leur procede de production et composition pharmaceutique les contenant
FR2567519B1 (fr) Nouvelles isoindolinyl-alcoyl-piperazines, compositions pharmaceutiques les contenant, et leur procede de preparation
BE885156A (fr) Psoralenes, leur procede de preparation et compositions pharmaceutiques les contenant
OA07585A (fr) Nouveaux composés hétérocycliques, leur procédé de préparation et composition pharmaceutique les contenant.
BE867249A (fr) Nouveaux trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido (4,3-b) indoles, leur procede de preparation et composition pharmaceutique les contenant
BE884083A (fr) Nouveaux oxime-ethers, leur procede de preparation et compositions pharmaceutiques les contenant
FR2286643A1 (fr) Nouveaux triiodocarbanilates, leur procede de preparation et composition pharmaceutique les contenant
FR2303559A1 (fr) Nouveaux derives d'histidine, leur procede de preparation et composition pharmaceutique les contenant
FR2340943A1 (fr) Nouvelles 2-phenyl-5-(5-1h-tetrazolyl) pyrimidine-4(3h)-ones, leur procede de preparation et composition pharmaceutique les contenant
BE825245A (fr) Nouvelles 2-amino-6-dialkylaminodihydropyridines leur procede de preparation et medicament les contenant
FR2601951B1 (fr) Nouvelles tetrahydrocarbazolones, composition pharmaceutique les contenant et leur procede de preparation
BE844065A (fr) Nouvelles 2-phenylimino-thiazolines substituees, leur procede de preparation et compositions ectoparasiticides les contenant
BE866745A (fr) Nouveaux derives de phenylglycine, leur procede de preparation et composition pharmaceutique les contenant
BE849047A (fr) Nouvelles 2-(p-naphtyloxy)-ethylpyrazolones, leur procede de preparation et medicament les contenant
BE872023A (fr) Derives de 4-amino-2-piperidinoquinazoline, leur procede de production et composition pharmaceutique les contenant

Legal Events

Date Code Title Description
ST Notification of lapse